Search results

The purpose of this paper is to describe trends since 2000 in young people's use of illegal/illicit drugs in Britain, and to place these into a longer‐term context alongside recent theorising on youthful drug taking. The implications for health educators are to be examined.

A selective narrative review of published data and theory forms the approach.

A steady rise in the prevalence of youthful drug taking in Britain from the 1960s was followed by a sharper rise from 1990 to an all‐time peak in the middle of that decade. Rates have not quite returned to this peak since, and from 2000 onwards have declined steadily, though from a historically high level. By 2006/2007, roughly one in five younger adolescents, and one in four older adolescents and young adults, has taken an illegal/illicit drug in the past year. In spite of changes over the past two decades, youthful drug taking in Britain over this period is characterised by considerable continuity. Gender and socio‐economic differences in drug taking over this period have remained roughly stable, but changes may be under way in relation to differences by ethnic background.

In Britain, levels of youthful drug taking remain at historically relatively high levels, with recent decreases at least in part probably due to a cohort effect of the drug‐involved generation who were teenagers in the 1990s moving into their 30s. Drugs education is not the likely cause of the post‐2000 downward trend. Drug “journeys” and the pursuit of pleasure are important considerations for health educators who aim their messages at the majority of young people whose drug use is not seriously problematic, and who are proactive when they do experience problems.

This paper calls for health educators also to focus on the majority of youthful drug use that is relatively unproblematic for young people. These young people require information as they make adjustments in their behaviour, and their needs may sometimes be ignored in favour of those with problematic drug use.

Research suggests that student drug use is substantially higher than that of the general population and while the UK Government’s current Drug Strategy emphasises the importance of PSHE in preventing young people from becoming drug users, there is a lack of research investigating the longer-term effectiveness of drug prevention education, and students’ views using qualitative methods. The purpose of this paper is to gain a holistic understanding into university students’ lived experiences of recreational class A drug taking and the drug education taught in English secondary schools.

Five interviews with university students were undertaken and thematically analysed using an ideographic case study approach alongside a qualitative content analysis of publicly available drug education resources and policy documents.

The normalisation of drug taking at university and social micro-pressures to assimilate group norms were key contributing factors to participants’ drug use. While the content of drug education in PSHE is grounded in theory, its implementation is not.

This study extends upon existing theories of normalisation of drug use at university through the concept of micro-pressures to offer an explanation of the process by which students assimilate group norms through the implicit threat of not fitting in.

The doubling of obesity in the U.S. over the last 25 years has led policymakers and physicians to encourage weight loss, but few methods of weight loss are effective. One promising avenue is pharmacotherapy. However, little is known about the use of anti-obesity drugs. This paper describes the market for anti-obesity drugs and studies the utilization of anti-obesity drugs using data from the Medical Expenditure Panel Survey for 1996–2002, a period that is interesting because it covers the introduction of three, and the withdrawal of two, anti-obesity drugs from the market.

Our results point to wide sociodemographic disparities in anti-obesity drug use. Women are almost 200% more likely than men to use anti-obesity drugs. Hispanics and African-Americans are only 39% as likely as Whites to use them. Those with prescription drug coverage are 46% more likely to use anti-obesity drugs.

We also find that the vast majority of subjects who are approved to take these drugs are not taking them, and a significant number who are not approved to take the drugs are taking them. We find strong evidence that the well-publicized 1997 withdrawal of fenfluramine and dexfenfluramine had a chilling effect on the overall market for anti-obesity drugs. We find little difference in observed characteristics between those who took the withdrawn drugs and those who took the other anti-obesity drugs in the market.

The purpose of this study is to examine the underresearched transformative service research (TSR) and social marketing segment of young adults who use drugs and identify motivators that have been studied in previous literature, using a service ecosystem lens and provide direction for future research into this area. This research provides the evidence-based knowledge for transformative service and social marketing practitioners to design transformative services that target these motivators.

This systematic review, guided by the preferred reporting items for systematic reviews and meta-analysis framework, examines and analyses 207 articles published between 2015 and 2020.

This study identified that young adults are motivated to take drugs to enhance one’s experience, to cope, for social reasons, because of individual characteristics and for other reasons. Research has largely focused on microsystem and mesosystem motivators with data collected mainly using a microsystem approach.

This paper contributes to the TSR and social marketing literature by providing a holistic investigation into all motivators relevant to young adult drug use. An ecosystem classification and theoretical framework of the motivators is curated to help guide future TSR and social marketing research and interventions.

The vast majority of young drug users see substance use as a positive experience. Why else would they continue to take them? Most research on the other hand pathologises drug use by looking solely at the negative consequences, contributing to the misunderstanding that young people are increasingly self‐indulgent and, in a meaningless world, hell‐bent on self‐destruction. In this refreshing new article Karenza Moore and Steven Miles try to understand the social roles of drug use in the everchanging lives of young people and come up with an alternative view. Rather than seeing drugs as a destructive force, Moore and Miles portray drug‐taking as a stabilising factor in the volatile world of growing up.

Explaining the purpose behind Release's Popular Nice People Take Drugs campaign, this article suggests that drug policy organisations need to engage more widely with the public to generate greater support for policy reform. The stigma currently attached to drug use and drug users stifles debate and prevents constructive discussion taking place about the approach that society should be taking towards drugs.

The purpose of this paper is to explore polydrug use and the factors that motivate the use of multiple substances among selected young adults.

A total of 23 male and female participants (aged 23-29 years) who use illicit drugs and prescription pharmaceuticals for non-medical purposes were recruited through snowball sampling. Qualitative interviews were conducted, and the data were analysed thematically.

The use of drug “concoctions” and cocktails was widespread among the participants. Some used what they called Codeine Diet (codeine-based cough syrup mixed with a Coca-Cola^® product or malt drink), while others took Gutter Water (a cocktail of cannabis, codeine, tramadol, vodka and juice or water). The use of Monkey Tail (a mixture of local gin, cannabis leaves, stems, roots and seeds) and petrol mixed with glue and La Casera^® (carbonated soft drink) combined with Tom-Tom^® (menthol-flavoured candy) was also revealed. Pleasure, better highs, the need to experience prolonged intoxication and the use of one drug to douse the effects of another substance motivated polysubstance use.

The findings revealed that the reasons why codeine-based cough syrups are mixed with soft drinks (Codeine Diet) include avoiding social discrimination and evading law enforcement agencies. Results suggest that these drug use practices require specifically tailored public health interventions. Social stigmatization against substance users and the use of extra-legal measures by the police should be discouraged to facilitate harm reduction.

This study represents the first qualitative research to explore polydrug use among an understudied Nigerian population.

This chapter takes the ‘wakefulness promoting’ drug modafinil as an exemplarity case in the sociology of pharmaceutical enhancement. The chapter draws on empirical data collected through 25 interviews with prospective users of modafinil, focusing on two of the ways in which prospective users of modafinil imagined how the drug might be used in their specific social domains: the use of modafinil as a safety tool in the workplace and its use as a study aid by university students. The data presented in this chapter suggests that although a therapy-enhancement dichotomy is a useful heuristic; it could also be limiting to uphold as it may direct attention away from other ways in which uses for new technologies can be positioned, negotiated, realised and resisted by (potential) users in the context of their daily lives.